tiprankstipranks
Trending News
More News >
Imac Holdings (BACK)
OTHER OTC:BACK
US Market

Imac Holdings (BACK) AI Stock Analysis

Compare
178 Followers

Top Page

BACK

Imac Holdings

(OTC:BACK)

Select Model
Select Model
Select Model
Underperform 25 (OpenAI - 4o)
Rating:25Underperform
Price Target:
IMAC Holdings has a low overall stock score due to significant financial challenges, negative valuation metrics, and technical indicators suggesting weak momentum. The risk of Nasdaq delisting further exacerbates the company's precarious position. The lack of earnings call data limits further insights into potential strategic actions or improvements.
Positive Factors
Innovative Care Solutions
IMAC's focus on innovative, non-invasive treatments positions it well in the growing market for alternatives to traditional surgery, potentially driving long-term demand.
Niche Market Position
By targeting patients seeking non-surgical options, IMAC taps into a specialized market, which can lead to sustained revenue growth as demand for such services increases.
No Immediate Debt
The absence of immediate debt liabilities provides some financial flexibility, allowing IMAC to focus resources on operational improvements and strategic growth without the burden of debt servicing.
Negative Factors
Nasdaq Compliance Challenges
Non-compliance with Nasdaq listing rules poses a risk of delisting, which could limit access to capital markets and negatively impact investor confidence.
Declining Revenues
Persistent revenue decline indicates challenges in maintaining market share and profitability, which could hinder long-term growth and financial stability.
Negative Cash Flow
Negative cash flow reflects poor cash generation, limiting the company's ability to invest in growth opportunities and meet operational needs, impacting long-term viability.

Imac Holdings (BACK) vs. SPDR S&P 500 ETF (SPY)

Imac Holdings Business Overview & Revenue Model

Company DescriptionIMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides physical therapy and spinal decompression, and chiropractic manipulation. The company owns or manages 15 outpatient medical clinics in Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Brentwood, Tennessee.
How the Company Makes MoneyIMAC Holdings generates revenue primarily through the operation of its medical clinics, which provide a range of healthcare services such as physical therapy, chiropractic care, and regenerative medicine treatments. These services cater to patients seeking alternatives to traditional surgical procedures, allowing the company to capture a niche market within the healthcare industry. Revenue is driven by patient visits, treatment plans, and insurance reimbursements. Additionally, the company may engage in partnerships or collaborations with healthcare providers and specialists to expand its service offerings and reach a broader customer base. While specific financial data and partnerships were not available, the company's focus on innovative care solutions positions it to capitalize on growing demand for non-invasive healthcare options.

Imac Holdings Financial Statement Overview

Summary
IMAC Holdings is facing substantial financial difficulties across income, balance sheet, and cash flow metrics. The company struggles with declining revenues and continuous losses, reflected in negative profit margins and equity. Despite no debt in the TTM, the lack of cash generation and equity poses a significant risk to financial health and sustainability.
Income Statement
The company has been experiencing significant revenue declines, with a negative revenue growth rate in the TTM. Profit margins are severely negative across all major metrics, indicating ongoing operational challenges. Gross profit margin, net profit margin, EBIT, and EBITDA margins are all unfavorable, underscoring the lack of profitability.
Balance Sheet
The balance sheet reveals minimal stockholders' equity, leading to high leverage. However, the absence of debt in the TTM indicates no immediate financial liabilities, which could mitigate some risks. ROE is negative due to persistent net losses, and the equity ratio is extremely low, highlighting financial instability.
Cash Flow
Cash flow performance is concerning, with substantial negative operating and free cash flows in the TTM. The free cash flow growth rate is negative, marking a worsening situation. Operating and free cash flow to net income ratios are not favorable, indicating poor cash generation relative to losses.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue22.72K72.05K5.20M16.19M14.39M12.84M
Gross Profit-417.84K-233.20K3.85M14.68M12.76M11.21M
EBITDA-8.89M-5.48M-5.95M-10.20M-8.39M-3.26M
Net Income-9.70M-9.05M-9.42M-18.31M-10.54M-5.57M
Balance Sheet
Total Assets310.06K1.59M1.14M11.08M27.23M19.75M
Cash, Cash Equivalents and Short-Term Investments45.05K504.19K221.51K763.21K7.12M2.62M
Total Debt0.000.000.004.16M5.90M9.14M
Total Liabilities0.007.98M1.90M6.43M9.28M11.93M
Stockholders Equity0.00-6.39M-752.65K4.65M17.95M10.43M
Cash Flow
Free Cash Flow-4.89M-3.16M-2.79M-10.63M-8.29M-6.12M
Operating Cash Flow-4.89M-3.16M-2.79M-10.29M-7.59M-5.99M
Investing Cash Flow0.00-375.00K-1.78M-259.98K-2.46M-569.74K
Financing Cash Flow4.75M3.82M4.02M4.20M14.54M8.81M

Imac Holdings Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price0.13
Price Trends
50DMA
0.10
Positive
100DMA
0.09
Positive
200DMA
0.07
Positive
Market Momentum
MACD
<0.01
Positive
RSI
50.12
Neutral
STOCH
16.29
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BACK, the sentiment is Neutral. The current price of 0.13 is below the 20-day moving average (MA) of 0.14, above the 50-day MA of 0.10, and above the 200-day MA of 0.07, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 50.12 is Neutral, neither overbought nor oversold. The STOCH value of 16.29 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for BACK.

Imac Holdings Risk Analysis

Imac Holdings disclosed 45 risk factors in its most recent earnings report. Imac Holdings reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Imac Holdings Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
51
Neutral
$14.20M-6.38-8.75%17.84%-156.13%
49
Neutral
$133.50M70.99-1.37%-54.93%
44
Neutral
$29.08M-60.9811.14%-0.29%94.56%
43
Neutral
$24.43M-0.08-257.39%-2.15%-6.72%
42
Neutral
$3.01M-0.13-99.99%-44.29%44.12%
25
Underperform
$507.19K-0.02
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
BACK
Imac Holdings
0.13
-1.08
-88.93%
AMS
American Shared Hospital Services
2.17
-0.89
-29.08%
JYNT
Joint
8.98
-1.35
-13.07%
CCEL
Cryo-Cell International
3.61
-3.21
-47.07%
PIII
P3 Health Partners
3.39
-7.35
-68.44%
MNDR
Mobile-health Network Solutions Class A
1.02
-15.23
-93.72%

Imac Holdings Corporate Events

Private Placements and Financing
IMAC Holdings Secures Promissory Note for Financial Stability
Neutral
Dec 16, 2025

On December 11, 2025, IMAC Holdings, Inc. issued a secured promissory note to a lender for $247,800 with a purchase price of $177,000, maturing on February 13, 2026. This financial move allows the company to prepay the principal without penalty and includes standard financial covenants and default conditions, potentially impacting its financial stability and stakeholder interests.

Private Placements and Financing
IMAC Holdings Issues Secured Promissory Note
Neutral
Dec 1, 2025

On November 25, 2025, IMAC Holdings, Inc. issued a secured promissory note to a lender for $245,000, with a purchase price of $175,000. The note, which matures on February 13, 2026, allows for prepayment without penalty and includes standard covenants and default events, such as bankruptcy, which could accelerate repayment obligations.

Private Placements and Financing
IMAC Holdings Issues Secured Promissory Note
Neutral
Nov 20, 2025

On November 14, 2025, IMAC Holdings, Inc. issued a secured promissory note to a lender for $210,000, with a purchase price of $150,000, maturing on February 13, 2026. The note allows prepayment without penalty and includes standard legal protections and conditions, with implications for immediate repayment in case of default, including bankruptcy or insolvency.

Private Placements and Financing
IMAC Holdings Issues Promissory Note for Liquidity
Neutral
Oct 31, 2025

On October 28, 2025, IMAC Holdings, Inc. issued an unsecured promissory note to a lender for $285,600, with a purchase price of $204,000, maturing on December 24, 2025. This financial maneuver allows the company flexibility in prepayment and includes standard conditions and events of default, reflecting strategic financial management to potentially enhance liquidity.

Private Placements and Financing
IMAC Holdings Issues Unsecured Promissory Note
Neutral
Oct 20, 2025

On October 14, 2025, IMAC Holdings, Inc. issued an unsecured promissory note to a lender for $201,600, with a purchase price of $144,000, maturing on December 24, 2025. The note allows for prepayment without penalty and includes standard clauses for default, impacting the company’s financial obligations and potential liquidity.

Private Placements and Financing
IMAC Holdings Issues Unsecured Promissory Note
Negative
Oct 3, 2025

On September 26, 2025, IMAC Holdings, Inc. issued an unsecured promissory note to a lender for $296,800, with a purchase price of $212,000. The note, which matures on December 24, 2025, allows for prepayment without penalty and includes standard covenants and default conditions, highlighting potential financial risks for the company.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 30, 2025